董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Louis E. Silverman | 男 | Independent Director | 66 | 24.60万美元 | 未持股 | 2025-06-25 |
| Elizabeth Yeu | 女 | Chairman of the Board | 46 | 未披露 | 未持股 | 2025-06-25 |
| Arthur C. Butcher | -- | Independent Director | -- | 未披露 | 未持股 | 2025-06-25 |
| Wei Jiang | -- | Independent Director | -- | 未披露 | 未持股 | 2025-06-25 |
| Lilian Zhou | -- | Independent Director | -- | 未披露 | 未持股 | 2025-06-25 |
| Stephen C. Farrell | 男 | Director and Chief Executive Officer | 60 | 20.00万美元 | 未持股 | 2025-06-25 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Warren Foust | -- | President and Chief Operating Officer | -- | 未披露 | 未持股 | 2025-06-25 |
| Magda Michna | -- | Chief Development Officer | -- | 未披露 | 未持股 | 2025-06-25 |
| Nathaniel B. Sisitsky | -- | Chief Legal Officer and Corporate Secretary | -- | 未披露 | 未持股 | 2025-06-25 |
| Stephen C. Farrell | 男 | Director and Chief Executive Officer | 60 | 20.00万美元 | 未持股 | 2025-06-25 |
| Deborah Andrews | 女 | Chief Financial Officer | 67 | 38.94万美元 | 未持股 | 2025-06-25 |
董事简历
中英对照 | 中文 | 英文- Louis E. Silverman
-
Louis E. Silverman，他曾一直担任私人公司Advanced ICU Care公司（医疗保健服务公司，为医院提供远程加护病房监控服务）的主席兼首席执行官。从2012年6月到2014年2月，他曾担任私人股权投资的顾问兼董事会顾问，涉及医疗技术和医疗服务组合投资。从2009年9月到2012年6月，他曾担任Marina Medical Billing Services公司（服务全国急诊科医生的收入周期管理公司）的首席执行官。此前，他曾担任高通支持医疗初创公司LifeComm的总裁兼首席执行官。从2000年8月到2008年8月，他也曾担任Quality Systems公司（医疗、牙科实践管理、病人记录软件的上市开发商）的总裁兼首席执行官。从1993年到2000年，他曾担任CorVel Corporation（上市国家管理式医疗服务科技公司）的首席运营官。他拥有Amherst College的学士学位，以及哈佛大学商学院 （ Harvard Business School ）的工商管理硕士学位。
Louis E. Silverman has served as the Chairperson and Chief Executive Officer of privately held Hicuity Health, Inc. formerly known as Advanced ICU Care, Inc., a health care services company providing remote patient monitoring services to hospitals. From June 2012 through February 2014 Mr. Silverman served as a consultant and Board advisor for private equity investors and others regarding health care technology and health care technology service companies, and health care services portfolio investments. From September 2009 through June 2012 Mr. Silverman was Chief Executive Officer of Marina Medical Billing Services, Inc., a revenue cycle management company serving ER physicians nationally. Previously, from September 2008 through August 2009 Mr. Silverman served as President and Chief Executive Officer of Qualcomm-backed health care start-up LifeComm. From August 2000 through August 2008 Mr. Silverman served as the President and Chief Executive officer of Quality Systems, Inc., a publicly traded developer of medical and dental practice management and patient records software. From 1993 through 2000 he served as Chief Operating Officer of CorVel Corporation, a publicly traded national managed care services/technology company. Mr. Silverman earned a B.A. from Amherst College and an M.B.A. from Harvard Business School. - Louis E. Silverman，他曾一直担任私人公司Advanced ICU Care公司（医疗保健服务公司，为医院提供远程加护病房监控服务）的主席兼首席执行官。从2012年6月到2014年2月，他曾担任私人股权投资的顾问兼董事会顾问，涉及医疗技术和医疗服务组合投资。从2009年9月到2012年6月，他曾担任Marina Medical Billing Services公司（服务全国急诊科医生的收入周期管理公司）的首席执行官。此前，他曾担任高通支持医疗初创公司LifeComm的总裁兼首席执行官。从2000年8月到2008年8月，他也曾担任Quality Systems公司（医疗、牙科实践管理、病人记录软件的上市开发商）的总裁兼首席执行官。从1993年到2000年，他曾担任CorVel Corporation（上市国家管理式医疗服务科技公司）的首席运营官。他拥有Amherst College的学士学位，以及哈佛大学商学院 （ Harvard Business School ）的工商管理硕士学位。
- Louis E. Silverman has served as the Chairperson and Chief Executive Officer of privately held Hicuity Health, Inc. formerly known as Advanced ICU Care, Inc., a health care services company providing remote patient monitoring services to hospitals. From June 2012 through February 2014 Mr. Silverman served as a consultant and Board advisor for private equity investors and others regarding health care technology and health care technology service companies, and health care services portfolio investments. From September 2009 through June 2012 Mr. Silverman was Chief Executive Officer of Marina Medical Billing Services, Inc., a revenue cycle management company serving ER physicians nationally. Previously, from September 2008 through August 2009 Mr. Silverman served as President and Chief Executive Officer of Qualcomm-backed health care start-up LifeComm. From August 2000 through August 2008 Mr. Silverman served as the President and Chief Executive officer of Quality Systems, Inc., a publicly traded developer of medical and dental practice management and patient records software. From 1993 through 2000 he served as Chief Operating Officer of CorVel Corporation, a publicly traded national managed care services/technology company. Mr. Silverman earned a B.A. from Amherst College and an M.B.A. from Harvard Business School.
- Elizabeth Yeu
-
Elizabeth Yeu自2014年以来一直是Virginia Eye Consultants的合伙人。她目前还担任美国白内障和屈光手术协会的秘书和执行委员会成员。Yeu博士是一位全国公认的眼科医生和教育家。她撰写了数百篇文章，并经常在屈光性白内障手术，眼前段重建，眼表疾病管理和散光手术管理领域担任讲师。Yeu博士被选为眼科医生权力榜2020年100强；权力榜2019年新兴领袖；权力榜2017年后起之秀；2015年40岁以下40强。她被眼科创新峰会确定为2018年临床后起之秀，被公认为2016-2019年Castle Connelly顶级医生，并于2017年获得Castle Connelly Exceptive Women in Medicine Award。Yeu博士通过在佛罗里达大学医学院的加速和合并的本科/医学院课程获得了医学学位。Yeu博士完成了她在拉什大学医学中心的实习，并在贝勒医学院获得了角膜，前段和屈光手术奖学金。
Elizabeth Yeu, has been a Partner at Virginia Eye Consultants since 2014. She also currently serves as Secretary and a member of the Executive Committee of the American Society of Cataract and Refractive Surgery ASCRS. Dr. Yeu is a nationally recognized ophthalmologist and educator. She has authored hundreds of articles and is a frequent lecturer in the areas of refractive cataract surgery, anterior segment reconstruction, ocular surface disease management and surgical management of astigmatism. Dr. Yeu was voted to The Ophthalmologist's Power List 2020 Top 100; Power List 2019 Emerging Leader; Power List 2017 Rising Stars; and 2015 Top 40 Under 40. She was identified as a Clinical Rising Star 2018 by the Ophthalmic Innovations Summit (OIS), was recognized as a Castle Connelly Top Doc 2016-2019 and received the Castle Connelly Exceptional Women in Medicine Award in 2017. Dr. Yeu earned her medical degree through an accelerated and combined undergraduate/medical school program at the University of Florida College of Medicine. Dr. Yeu completed her residency at Rush University Medical Center and fellowship in cornea, anterior segment and refractive surgery at Baylor College of Medicine. - Elizabeth Yeu自2014年以来一直是Virginia Eye Consultants的合伙人。她目前还担任美国白内障和屈光手术协会的秘书和执行委员会成员。Yeu博士是一位全国公认的眼科医生和教育家。她撰写了数百篇文章，并经常在屈光性白内障手术，眼前段重建，眼表疾病管理和散光手术管理领域担任讲师。Yeu博士被选为眼科医生权力榜2020年100强；权力榜2019年新兴领袖；权力榜2017年后起之秀；2015年40岁以下40强。她被眼科创新峰会确定为2018年临床后起之秀，被公认为2016-2019年Castle Connelly顶级医生，并于2017年获得Castle Connelly Exceptive Women in Medicine Award。Yeu博士通过在佛罗里达大学医学院的加速和合并的本科/医学院课程获得了医学学位。Yeu博士完成了她在拉什大学医学中心的实习，并在贝勒医学院获得了角膜，前段和屈光手术奖学金。
- Elizabeth Yeu, has been a Partner at Virginia Eye Consultants since 2014. She also currently serves as Secretary and a member of the Executive Committee of the American Society of Cataract and Refractive Surgery ASCRS. Dr. Yeu is a nationally recognized ophthalmologist and educator. She has authored hundreds of articles and is a frequent lecturer in the areas of refractive cataract surgery, anterior segment reconstruction, ocular surface disease management and surgical management of astigmatism. Dr. Yeu was voted to The Ophthalmologist's Power List 2020 Top 100; Power List 2019 Emerging Leader; Power List 2017 Rising Stars; and 2015 Top 40 Under 40. She was identified as a Clinical Rising Star 2018 by the Ophthalmic Innovations Summit (OIS), was recognized as a Castle Connelly Top Doc 2016-2019 and received the Castle Connelly Exceptional Women in Medicine Award in 2017. Dr. Yeu earned her medical degree through an accelerated and combined undergraduate/medical school program at the University of Florida College of Medicine. Dr. Yeu completed her residency at Rush University Medical Center and fellowship in cornea, anterior segment and refractive surgery at Baylor College of Medicine.
- Arthur C. Butcher
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Wei Jiang
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Lilian Zhou
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Stephen C. Farrell
-
Stephen C. Farrell是Stephen C. Farrell的首席执行官，也是Stephen C. Farrell董事会的成员。2011年2月以来，他一直担任Convey Health Solutions公司（医疗业务流程外包公司）的首席执行官。他此前曾担任PolyMedica Corporation的总裁，直到PolyMedica公司被Medco Health Solutions公司收购。他曾任职PolyMedica公司8年，担任多种职务，包括总裁、首席运营官、首席财务官、首席合规官、财务主管。他曾担任Stream Global Services公司（全球业务流程外包公司。拥有17000名员工）的执行副总裁兼首席财务官。职业生涯早期，他曾担任普华永道（PricewaterhouseCoopers）的高级经理。他是Core Contracting Services公司（创业环境修复和拆迁公司）的创始人。他目前任职于BioTime公司（一个生物科技公司专注于再生医学，再生医学是医疗产品开发的一个新兴领域，基于干细胞研究的技术开发）的董事会。他于2013年3月加入BioTime公司。他拥有哈佛大学（Harvard University）的学士学位，以及佛吉利亚大学（The University of Virginia）的工商管理硕士学位。他曾是注册会计师（从1998年到2012年）。
Stephen C. Farrell has served since 2011 as the Chief Executive Officer and a member of the Board of Directors of Convey Health Solutions, a private equity sponsored technology-enabled healthcare business process outsourcer. Also, from 2012 to 2020 he has served as a member of the Board of Directors of Lineage Cell Therapeutics, formerly known as BioTime, Inc., a clinical stage biotechnology company focused in the field of regenerative medicine. From 2008 to 2009 Mr. Farrell served as the Executive Vice President and Chief Financial Officer for Stream Global Services, a business process outsourcer. From 1999 to 2007 Mr. Farrell served as President of PolyMedica Corporation, a publicly traded provider of diabetes supplies that was acquired by Medco Health Solutions in 2007. From 2007 to 2014 he served as a member of the Board of Directors of Questcor Pharmaceuticals, a biopharmaceutical company that was acquired by Mallinckrodt PLC in 2014. Mr. Farrell spent five years as a Senior Manager at PricewaterhouseCoopers auditing leading public companies from 1994 to 1999. He received his B.A. from Harvard University and earned a M.B.A. at the University of Virginia, Darden School of Business. - Stephen C. Farrell是Stephen C. Farrell的首席执行官，也是Stephen C. Farrell董事会的成员。2011年2月以来，他一直担任Convey Health Solutions公司（医疗业务流程外包公司）的首席执行官。他此前曾担任PolyMedica Corporation的总裁，直到PolyMedica公司被Medco Health Solutions公司收购。他曾任职PolyMedica公司8年，担任多种职务，包括总裁、首席运营官、首席财务官、首席合规官、财务主管。他曾担任Stream Global Services公司（全球业务流程外包公司。拥有17000名员工）的执行副总裁兼首席财务官。职业生涯早期，他曾担任普华永道（PricewaterhouseCoopers）的高级经理。他是Core Contracting Services公司（创业环境修复和拆迁公司）的创始人。他目前任职于BioTime公司（一个生物科技公司专注于再生医学，再生医学是医疗产品开发的一个新兴领域，基于干细胞研究的技术开发）的董事会。他于2013年3月加入BioTime公司。他拥有哈佛大学（Harvard University）的学士学位，以及佛吉利亚大学（The University of Virginia）的工商管理硕士学位。他曾是注册会计师（从1998年到2012年）。
- Stephen C. Farrell has served since 2011 as the Chief Executive Officer and a member of the Board of Directors of Convey Health Solutions, a private equity sponsored technology-enabled healthcare business process outsourcer. Also, from 2012 to 2020 he has served as a member of the Board of Directors of Lineage Cell Therapeutics, formerly known as BioTime, Inc., a clinical stage biotechnology company focused in the field of regenerative medicine. From 2008 to 2009 Mr. Farrell served as the Executive Vice President and Chief Financial Officer for Stream Global Services, a business process outsourcer. From 1999 to 2007 Mr. Farrell served as President of PolyMedica Corporation, a publicly traded provider of diabetes supplies that was acquired by Medco Health Solutions in 2007. From 2007 to 2014 he served as a member of the Board of Directors of Questcor Pharmaceuticals, a biopharmaceutical company that was acquired by Mallinckrodt PLC in 2014. Mr. Farrell spent five years as a Senior Manager at PricewaterhouseCoopers auditing leading public companies from 1994 to 1999. He received his B.A. from Harvard University and earned a M.B.A. at the University of Virginia, Darden School of Business.
高管简历
中英对照 | 中文 | 英文- Warren Foust
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- Magda Michna
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- Nathaniel B. Sisitsky
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- Stephen C. Farrell
Stephen C. Farrell是Stephen C. Farrell的首席执行官，也是Stephen C. Farrell董事会的成员。2011年2月以来，他一直担任Convey Health Solutions公司（医疗业务流程外包公司）的首席执行官。他此前曾担任PolyMedica Corporation的总裁，直到PolyMedica公司被Medco Health Solutions公司收购。他曾任职PolyMedica公司8年，担任多种职务，包括总裁、首席运营官、首席财务官、首席合规官、财务主管。他曾担任Stream Global Services公司（全球业务流程外包公司。拥有17000名员工）的执行副总裁兼首席财务官。职业生涯早期，他曾担任普华永道（PricewaterhouseCoopers）的高级经理。他是Core Contracting Services公司（创业环境修复和拆迁公司）的创始人。他目前任职于BioTime公司（一个生物科技公司专注于再生医学，再生医学是医疗产品开发的一个新兴领域，基于干细胞研究的技术开发）的董事会。他于2013年3月加入BioTime公司。他拥有哈佛大学（Harvard University）的学士学位，以及佛吉利亚大学（The University of Virginia）的工商管理硕士学位。他曾是注册会计师（从1998年到2012年）。
Stephen C. Farrell has served since 2011 as the Chief Executive Officer and a member of the Board of Directors of Convey Health Solutions, a private equity sponsored technology-enabled healthcare business process outsourcer. Also, from 2012 to 2020 he has served as a member of the Board of Directors of Lineage Cell Therapeutics, formerly known as BioTime, Inc., a clinical stage biotechnology company focused in the field of regenerative medicine. From 2008 to 2009 Mr. Farrell served as the Executive Vice President and Chief Financial Officer for Stream Global Services, a business process outsourcer. From 1999 to 2007 Mr. Farrell served as President of PolyMedica Corporation, a publicly traded provider of diabetes supplies that was acquired by Medco Health Solutions in 2007. From 2007 to 2014 he served as a member of the Board of Directors of Questcor Pharmaceuticals, a biopharmaceutical company that was acquired by Mallinckrodt PLC in 2014. Mr. Farrell spent five years as a Senior Manager at PricewaterhouseCoopers auditing leading public companies from 1994 to 1999. He received his B.A. from Harvard University and earned a M.B.A. at the University of Virginia, Darden School of Business.- Stephen C. Farrell是Stephen C. Farrell的首席执行官，也是Stephen C. Farrell董事会的成员。2011年2月以来，他一直担任Convey Health Solutions公司（医疗业务流程外包公司）的首席执行官。他此前曾担任PolyMedica Corporation的总裁，直到PolyMedica公司被Medco Health Solutions公司收购。他曾任职PolyMedica公司8年，担任多种职务，包括总裁、首席运营官、首席财务官、首席合规官、财务主管。他曾担任Stream Global Services公司（全球业务流程外包公司。拥有17000名员工）的执行副总裁兼首席财务官。职业生涯早期，他曾担任普华永道（PricewaterhouseCoopers）的高级经理。他是Core Contracting Services公司（创业环境修复和拆迁公司）的创始人。他目前任职于BioTime公司（一个生物科技公司专注于再生医学，再生医学是医疗产品开发的一个新兴领域，基于干细胞研究的技术开发）的董事会。他于2013年3月加入BioTime公司。他拥有哈佛大学（Harvard University）的学士学位，以及佛吉利亚大学（The University of Virginia）的工商管理硕士学位。他曾是注册会计师（从1998年到2012年）。
- Stephen C. Farrell has served since 2011 as the Chief Executive Officer and a member of the Board of Directors of Convey Health Solutions, a private equity sponsored technology-enabled healthcare business process outsourcer. Also, from 2012 to 2020 he has served as a member of the Board of Directors of Lineage Cell Therapeutics, formerly known as BioTime, Inc., a clinical stage biotechnology company focused in the field of regenerative medicine. From 2008 to 2009 Mr. Farrell served as the Executive Vice President and Chief Financial Officer for Stream Global Services, a business process outsourcer. From 1999 to 2007 Mr. Farrell served as President of PolyMedica Corporation, a publicly traded provider of diabetes supplies that was acquired by Medco Health Solutions in 2007. From 2007 to 2014 he served as a member of the Board of Directors of Questcor Pharmaceuticals, a biopharmaceutical company that was acquired by Mallinckrodt PLC in 2014. Mr. Farrell spent five years as a Senior Manager at PricewaterhouseCoopers auditing leading public companies from 1994 to 1999. He received his B.A. from Harvard University and earned a M.B.A. at the University of Virginia, Darden School of Business.
- Deborah Andrews
Deborah Andrews自2013年9月起任一家上市的生物技术公司BioTime, Inc.的首席会计师，自2014年4月起任董事会和审计委员会成员，该公司专注于再生药物的新兴领域。在这之前，2005年8月至2013年9月Andrews女士曾是STAAR的副总裁兼首席财务官，她从1995年开始就在STAAR工作，2005年4月至2005年8月任STAAR财务总监，2001年至2005年任全球财务总监，1999年至2001年任STAAR Surgical AG Switzerland财务副总裁，1995年至1999年任财务总监助理。1994年至1995年她是电子元件制造商Bourns, Inc.的内部审计员，1991年至1994年是KPMG Peat Marwick的一名审计员。Andrews女士获得了圣贝纳迪诺的California State University的会计学学士学位。
Deborah Andrews,served as Chief Financial Officer of STAAR Surgical Company (STAA), a leader in the development, manufacture, and marketing of minimally invasive ophthalmic products employing proprietary technologies, from September 2017 until June 2020, after serving as Vice President, Chief Accounting Officer since 2013. Ms. Andrews also served as STAAR Surgical's Vice President, Chief Financial Officer from 2005 to 2013, as its Global Controller from 2001 to 2005, and as its Vice President, International Finance from 1999 to 2001. Ms. Andrews previously worked as a senior accountant for a major public accounting firm. Ms. Andrews holds a B.S. degree in accounting from California State University at San Bernardino.- Deborah Andrews自2013年9月起任一家上市的生物技术公司BioTime, Inc.的首席会计师，自2014年4月起任董事会和审计委员会成员，该公司专注于再生药物的新兴领域。在这之前，2005年8月至2013年9月Andrews女士曾是STAAR的副总裁兼首席财务官，她从1995年开始就在STAAR工作，2005年4月至2005年8月任STAAR财务总监，2001年至2005年任全球财务总监，1999年至2001年任STAAR Surgical AG Switzerland财务副总裁，1995年至1999年任财务总监助理。1994年至1995年她是电子元件制造商Bourns, Inc.的内部审计员，1991年至1994年是KPMG Peat Marwick的一名审计员。Andrews女士获得了圣贝纳迪诺的California State University的会计学学士学位。
- Deborah Andrews,served as Chief Financial Officer of STAAR Surgical Company (STAA), a leader in the development, manufacture, and marketing of minimally invasive ophthalmic products employing proprietary technologies, from September 2017 until June 2020, after serving as Vice President, Chief Accounting Officer since 2013. Ms. Andrews also served as STAAR Surgical's Vice President, Chief Financial Officer from 2005 to 2013, as its Global Controller from 2001 to 2005, and as its Vice President, International Finance from 1999 to 2001. Ms. Andrews previously worked as a senior accountant for a major public accounting firm. Ms. Andrews holds a B.S. degree in accounting from California State University at San Bernardino.